Contact
Please use this form to send email to PR contact of this press release:
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib
TO:
Please use this form to send email to PR contact of this press release:
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with the PARP Inhibitor Talazoparib
TO: